SANTA BARBARA, Calif.--(BUSINESS WIRE)--Mentor Corporation (NYSE:MNT), a leading supplier of medical products for the global aesthetic medicine market, today announced that it has entered into a commercialization agreement with Genzyme Corporation (Nasdaq:GENZ) under which Genzyme will develop future hyaluronic acid (“HA”) dermal filler products. Terms of the agreement were not disclosed.
